Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. Sleep aids help to improve the quality of sleep by reducing the time required to fall asleep and increasing the duration of quality sleep. The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023.
The global sleep aids market is segmented based on product, sleep disorder, and geography. Based on product, it is categorized into mattress & pillows, sleep laboratories, medications, and sleep apnea devices. The medications segment is further divided into prescription-based drugs, over-the-counter (OTC) drugs, and herbal drugs. Based on sleep disorder, it is classified into insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and other sleep disorder. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle. The surge in disposable income; increase in awareness about sleep disorders; stressful work issues; enhanced intake of caffeine, tobacco, and alcohol; and technological advancements are expected to boost the sleep aids market growth. However, adverse effects of sleep aids medication in patient with sleep disorders, such as dizziness, diarrhea, constipation, daytime drowsiness; and expiration on sleep drugs patents are expected to hamper the market growth.
KEY MARKET BENEFITS
KEY PLAYERS PROFILED
Sleep Aids Market Key Segments
BY PRODUCT
BY SLEEP DISORDER
BY GEOGRAPHY
The other players of the sleep aids market include (companies not profiled in the report):
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY BENEFITS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENT ANALYSIS
3.3.1. Patent analysis by year
3.3.2. Patent analysis by region
3.3.3. Patent analysis by sleep disorder
3.4. GOVERNMENT REGULATIONS
3.4.1. U.S. FDA
3.4.2. Europe CE Mark
3.4.3. Ministry of Health, Labor, and Welfare (MHLW)
3.5. TOP PLAYERS POSITIONING, 2016
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Modern lifestyle increases the risk of sleep disorders
3.6.1.2. Stressful Work Condition and Working in Shifts
3.6.1.3. Rise in geriatric and obese population
3.6.2. Restraints
3.6.2.1. Adverse effects of sleep aid medication
3.6.2.2. Patent expiration
3.6.3. Opportunities
3.6.3.1. Technological Advancements Leading to Better Adoption
3.6.3.2. Untapped Markets in Developing Economies
CHAPTER 4 GLOBAL SLEEP AIDS MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MATTRESSES AND PILLOWS
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. SLEEP LABORATORIES
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. MEDICATIONS
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Prescription-based drugs
4.4.5. OTC drugs
4.5. SLEEP APNEA DEVICES
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 SLEEP AIDS MARKET, BY SLEEP DISORDER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INSOMNIA
5.2.1. Market size and forecast
5.3. SLEEP APNEA
5.3.1. Market size and forecast
5.4. RESTLESS LEGS SYNDROME
5.4.1. Market size and forecast
5.5. NARCOLEPSY
5.5.1. Market size and forecast
5.6. SLEEPWALKING
5.6.1. Market size and forecast
5.7. OTHERS
5.7.1. Market size and forecast
CHAPTER 6 SLEEP AIDS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. CADWELL INDUSTRIES INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. COMPUMEDICS LIMITED
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. DRIVE DEVILBISS HEALTHCARE
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. GLAXOSMITHKLINE PLC
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. MERCK & CO., INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. NATUS MEDICAL INCORPORATED
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6.6. Key strategic moves and developments
7.7. PFIZER INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. KONINKLIJKE PHILIPS N.V.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. SANOFI
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Product portfolio
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.10. SLEEPMED INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 2. SLEEP AIDS MATTRESS AND PILLOWS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 3. SLEEP AIDS SLEEP LABORATORIES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. SLEEP AIDS MEDICATIONS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 5. SLEEP AIDS PRESCRIPTION-BASED DRUGS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. SLEEP AIDS OTC DRUGS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. GLOBAL SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION)
TABLE 8. INSOMNIA SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. SLEEP APNEA SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. RESTLESS LEGS SYNDROME SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. NARCOLEPSY SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. SLEEPWALKING MEDICAL SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. OTHER SLEEP DISORDERS SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. NORTH AMERICA SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. EUROPE SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 19. EUROPE SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION)
TABLE 20. EUROPE SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION)
TABLE 21. EUROPE SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. ASIA-PACIFIC SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 23. ASIA-PACIFIC SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION)
TABLE 25. ASIA-PACIFIC SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26. LAMEA SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 27. LAMEA SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION)
TABLE 28. LAMEA SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION)
TABLE 29. LAMEA SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. CADWELL: COMPANY SNAPSHOT
TABLE 31. CADWELL: OPERATING SEGMENTS
TABLE 32. CADWELL: PRODUCT PORTFOLIO
TABLE 33. COMPUMEDICS: COMPANY SNAPSHOT
TABLE 34. COMPUMEDICS: OPERATING SEGMENTS
TABLE 35. DRIVE DEVILBISS HEALTHCARE: COMPANY SNAPSHOT
TABLE 36. DRIVE DEVILBISS HEALTHCARE: OPERATING SEGMENTS
TABLE 37. DRIVE DEVILBISS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 38. GSK: COMPANY SNAPSHOT
TABLE 39. GSK: OPERATING SEGMENTS
TABLE 40. MERCK: COMPANY SNAPSHOT
TABLE 41. MERCK: OPERATING SEGMENTS
TABLE 42. NATUS: PRODUCT PORTFOLIO
TABLE 43. NATUS: COMPANY SNAPSHOT
TABLE 44. NATUS: OPERATING SEGMENTS
TABLE 45. PFIZER: COMPANY SNAPSHOT
TABLE 46. PFIZER: OPERATING SEGMENTS
TABLE 47. PFIZER: PRODUCT PORTFOLIO
TABLE 48. PHILIPS: COMPANY SNAPSHOT
TABLE 49. PHILIPS: OPERATING SEGMENTS
TABLE 50. PHILIPS: PRODUCT PORTFOLIO
TABLE 51. SANOFI: COMPANY SNAPSHOT
TABLE 52. SANOFI: PRODUCT PORTFOLIO
TABLE 53. SLEEPMED: COMPANY SNAPSHOT
TABLE 54. SLEEPMED: OPERATING SEGMENTS
TABLE 55. SLEEPMED: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL SLEEP AIDS MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2017) (%)
FIGURE 4. TOP WINNING STRATEGIES IN SLEEP AIDS MARKET (2015-2017)
FIGURE 5. TOP WINNING STRATEGIES: TYPE AND NATURE
FIGURE 11. TOP PLAYER POSITIONING: GLOBAL SLEEP AIDS MARKET, 2016
FIGURE 12. GLOBAL SLEEP AIDS MARKET: RESTRAINTS AND DRIVERS
FIGURE 13. GLOBAL SLEEP AIDS MARKET SEGMENTATION, BY APPLICATION
FIGURE 14. U.S. SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 16. MEXICO SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 17. GERMANY SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 18. FRANCE SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 19. UK SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 20. ITALY SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 24. AUSTRALIA SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 25. INDIA SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 28. TURKEY SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 29. SAUDI ARABIA SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA SLEEP AIDS MARKET, 2016-2023 ($MILLION)
FIGURE 32. CADWELL: REVENUE, 2016-2016 ($MILLION)
FIGURE 33. CADWELL: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 34. COMPUMEDICS: REVENUE, 2016-2016 ($MILLION)
FIGURE 35. COMPUMEDICS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 36. DRIVE DEVILBISS HEALTHCARE: REVENUE, 2016-2016 ($MILLION)
FIGURE 37. DRIVE DEVILBISS HEALTHCARE: REVENUE SHARE BY PRODUCT TYPE, 2016 (%)
FIGURE 38. DRIVE DEVILBISS HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 39. GSK: REVENUE, 2016-2016 ($MILLION)
FIGURE 40. GSK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 41. GSK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 42. MERCK: REVENUE, 2016-2016 ($MILLION)
FIGURE 43. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. NATUS: REVENUE, 2016-2016 ($MILLION)
FIGURE 46. NATUS: REVENUE SHARE BY GEOGRAPHY, 2015 (%)
FIGURE 47. PFIZER: REVENUE, 2016-2016 ($MILLION)
FIGURE 48. PFIZER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 49. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 50. PHILIPS: REVENUE, 2016-2016 ($MILLION)
FIGURE 51. PHILIPS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 52. PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 53. SANOFI: REVENUE, 2016-2016 ($MILLION)
FIGURE 54. SANOFI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 55. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 56. SLEEPMED: REVENUE, 2016-2016 ($MILLION)
FIGURE 57. SLEEPMED: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 58. SLEEPMED: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
